Recursion Pharmaceuticals Inc To Host Ongoing Phase 1b/2 Trial Webinar Transcript - Thomson StreetEvents

Recursion Pharmaceuticals Inc To Host Ongoing Phase 1b/2 Trial Webinar Transcript

Recursion Pharmaceuticals Inc To Host Ongoing Phase 1b/2 Trial Webinar Transcript - Thomson StreetEvents
Recursion Pharmaceuticals Inc To Host Ongoing Phase 1b/2 Trial Webinar Transcript
Published Dec 08, 2025
6 pages (3479 words) — Published Dec 08, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of RXRX.OQ corporate analyst meeting

  
Brief Excerpt:

...Unidentified Company Representative It is my pleasure to present the results from the ongoing REC-4881 201 trial and our FAP natural history analysis. So let's start by reviewing some background on FAP so we can better understand the significance of our results. Familial Adenomatous Polyposis is a rare orphan disease caused by autosomal dominant mutations in the APC gene. As a result of this loss of APC, patients will develop hundreds of thousands of adenomas or polyps in their colon and rectum by their late 10s and early 20s. In the absence of surgery, these patients have a 100% risk of developing colorectal cancer by the age of 40. These precancerous adenomas progressively accumulate, and there is little evidence of spontaneous regression. As Najat mentioned, currently, there are no approved pharmacotherapies for FAP. Patients face a lifetime of endoscopic surveillance, frequent excisional interventions, and life altering surgeries that impact quality of life, morbidity, and long-term...

  
Report Type:

Transcript

Source:
Company:
Recursion Pharmaceuticals Inc
Ticker
RXRX.OQ
Time
1:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Recursion Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference Transcript – 2025-09-08 – US$ 54.00 – Edited Transcript of RXRX.OQ presentation 8-Sep-25 10:59am GMT

Recursion Pharmaceuticals Inc at Citi Biopharma Back to School Conference Transcript – 2025-09-03 – US$ 54.00 – Edited Transcript of RXRX.OQ presentation 3-Sep-25 10:59am GMT

Recursion Pharmaceuticals Inc Q2 2025 Earnings Call Transcript – 2025-08-05 – US$ 54.00 – Edited Transcript of RXRX.OQ earnings conference call or presentation 5-Aug-25 12:00pm GMT

Recursion Pharmaceuticals Inc Annual Shareholders Meeting Transcript – 2025-06-18 – US$ 54.00 – Edited Transcript of RXRX.OQ shareholder or annual meeting 18-Jun-25 6:00pm GMT

Recursion Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference Transcript – 2025-06-10 – US$ 54.00 – Edited Transcript of RXRX.OQ presentation 10-Jun-25 7:20pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Recursion Pharmaceuticals Inc To Host Ongoing Phase 1b/2 Trial Webinar Transcript" Dec 08, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Recursion-Pharmaceuticals-Inc-To-Host-Ongoing-Phase-1b-2-Trial-Webinar-T16593703>
  
APA:
Thomson StreetEvents. (2025). Recursion Pharmaceuticals Inc To Host Ongoing Phase 1b/2 Trial Webinar Transcript Dec 08, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Recursion-Pharmaceuticals-Inc-To-Host-Ongoing-Phase-1b-2-Trial-Webinar-T16593703>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.